Electra Therapeutics Inc. (ETRA) vs Keros Therapeutics, Inc. (KROS)

A side-by-side comparison of Electra Therapeutics Inc. and Keros Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ETRA

Electra Therapeutics Inc.

$203M

$9.58HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

KROS

Keros Therapeutics, Inc.

$224M

$11.28HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT

Total return — ETRA vs KROS

growth of $100 · dividends reinvested · last 1y

ETRA -26.5% (-26.5%/yr)KROS +1.4% (+1.4%/yr)KROS compounded faster over this window

ETRA KROS

Metrics side by side

Total return (annualized)

Metric	ETRA	KROS
Total return (1Y)	N/A	-27.62%
Total return CAGR (3Y)	N/A	-29.47%
Total return CAGR (5Y)	N/A	-21.98%

ETRA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ETRA analysis Full KROS analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.